Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epiduroscopic Adhesiolysis in FBSS and Surgery-Naïve Patients
NCT07411950Completed
- Sponsor
- EuroPainClinics
- Start
- Jan 2021
- Primary completion
- May 2025
- Modality
- Device-based Delivery, Therapeutic Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial of methylprednisolone, hyaluronidase and hypertonic saline in failed back surgery syndrome (FBSS), lumbar radiculopathy, chronic low back pain (CLBP) and 1 more (4 arms), sponsored by EuroPainClinics. Primary endpoints: EuroQol 5-Dimension 5-Level Index Value at 6 months, Leg Pain Numeric Rating Scale at 6 months and 2 more. Started Jan 2021; status: completed.
02
Drugs
methylprednisolonehyaluronidasehypertonic saline
03
Conditions
failed back surgery syndrome (FBSS)lumbar radiculopathychronic low back pain (CLBP)epidural fibrosis
Beyond the preview
Go deeper on NCT07411950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07411950.